Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 GBX | 0.00% | 0.00% | -16.67% |
Apr. 18 | Stocks recover some of recent Fed talk losses | AN |
Apr. 18 | Surgical Innovations Group Bags UK Distribution Contracts | MT |
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2023 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.67% | 5.85M | - | ||
-3.79% | 184B | C+ | ||
-0.84% | 108B | C | ||
-3.75% | 67.82B | A | ||
+3.45% | 51.05B | B- | ||
+9.04% | 44.67B | B- | ||
+3.40% | 41.78B | B+ | ||
+3.21% | 26.78B | B | ||
+3.66% | 26.59B | A- | ||
+15.23% | 25.86B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SUN Stock
- Ratings Surgical Innovations Group plc